Public annual accounts

PHIEGO PHARMA financials

Name: PHIEGO PHARMA financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for PHIEGO PHARMA, with comparable measures and links to available source documents.

Company overview

Registry number

0742531238

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for PHIEGO PHARMA

2025 versus 2024

Operating line: €71,274
EBITDA: €68,652
Total assets: €400,654
Equity: €119,349

EBITDA margin +96.3% · Equity ratio +29.8%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€71,274	€68,652	€400,654	€119,349	-
202431 Dec 2024	€47,285	€42,474	€403,719	€101,489	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report